About Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
Clinical Trials at Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
During the past decade, Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology"
#1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
According to Clinical.Site data, the most researched conditions in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology" are
"Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials), "Arthritis Juvenile Idiopathic" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Juvenile Idiopathic Arthritis" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
Most popular intervention types in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Tiragolumab" (2 trials) and "Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
The vast majority of trials in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology" are
8 trials for "All" genders.
Clinical Trials Status at Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology
Currently, there are NaN active trials in "Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".